Results 91 to 100 of about 6,898 (170)

Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial. [PDF]

Lancet Infect Dis
Kamya MR, Nankabirwa JI, Ebong C, Asua V, Kiggundu M, Orena S, Okitwi M, Tukwasibwe S, Agaba B, Kyabayinze D, Opigo J, Rutazana D, Binagwa B, Mugwanya E, Babirye S, Sebikaari G, Condo PM, Appiah G, Nsobya SL, Conrad MD, Rosenthal PJ, Moriarty LF, Yeka A.   +22 more
europepmc   +1 more source

Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study.

Lancet Glob Health
Suresh J, Zimmermann M, Maiteki C, Stahlfeld A, Pratt A, Mathanga DP, Staedke SG, Laufer MK, Drakeley C, Bever C, Cohee LM.   +10 more
europepmc   +1 more source

Retraction: Tick-borne rickettsioses, neglected emerging diseases in rural senegal. [PDF]

PLoS Negl Trop Dis
PLOS Neglected Tropical Diseases Editors.
europepmc   +1 more source

Amodiaquine Hydrochloride [PDF]

, 2020
openaire   +1 more source

Spatio-temporal trends of artemisinin-based combination therapy efficacy from 2010 to 2024 in sub-Saharan Africa: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Bohissou FET, Nassa GJW, Sondo P, Rouamba T, Inoue J, Kaboré B, Asua V, Held J, Tinto H.   +8 more
europepmc   +1 more source

Efficacy and Safety of Artesunate + Amodiaquine and Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Madagascar, 2020. [PDF]

Am J Trop Med Hyg
Harimanana A, Randriamiarinjatovo DNAL, Rakotomanga TA, Irinantenaina J, Moriarty LF, Laird V, Patel D, Abdallah RA, Zhiyong Z, Svigel SS, Kapesa L, Razafindrakoto J, Ralinoro F, Rason MA, Andriamananjara MN, Razanatsiorimalala S, Razafinjato C, Randrianarivelojosia M.   +17 more
europepmc   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source

Plasmodium falciparum isolates: ex vivo drug response. [PDF]

J Antimicrob Chemother
Adika E, Saiid S, Amoako EK, Sakyi ME, Osumanu A, Morang'a C, Dosoo D, Chirawurah JD, Awandare GA, Amambua-Ngwa A, Aniweh Y, Amenga-Etego LN.   +11 more
europepmc   +1 more source

Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine. [PDF]

Malar J
Mombo-Ngoma G, Ramharter M, Zoleko Manego R, Lell B, Bassat Q, Aide P, Maiga Ascofare O, Wells TNC, Djimde A, Ntoumi F, Kremsner PG.   +10 more
europepmc   +1 more source

Retraction: Coxiella burnetii in Humans and Ticks in Rural Senegal. [PDF]

PLoS Negl Trop Dis
PLOS Neglected Tropical Diseases Editors.
europepmc   +1 more source